Univ.-Prof. Mag. Dr. Harald Heinzl
Center for Medical Statistics,
Informatics, and Intelligent Systems
Medical University of Vienna, Spitalgasse 23, A-1090 Wien;
harald.heinzl@muv.ac.at
Vienna, April 17, 2019
Papers:
[1]
F.
Gamerith, G.J. Zlabinger, O. Scherak, G. Kolarz, M. Schemper, Harald Heinzl,
J.E. Menzel (1993): Differences in anti-Fab antibodies in adult and late onset
rheumatoid arthritis. Rheumatol. Int. 13: 107-112.
[2]
T.M.U.
Wagner, A. Adler, P. Sevelda, I. Assmann, C.F. Knepflé, K. Czerwenka, Harald
Heinzl, J.J. Ploem-Zaaijer (1994): Prognostic Significance of Cell DNA Content
in Early-Stage Ovarian Cancer (Figo Stages I and II/A) by Means of Automatic
Image Cytometry. Int. J. Cancer: 56, 167-172.
[3]
Joseph
D. Nanobashvili, Georg Stacher, Ursula Windberger, Robert Dudczak, Christian
Liegl, Vasili Gorgadze, Udo Losert, Harald Heinzl, Christoph Neumayer (1994):
Regenerative potential of abdominal vagal nerves in rats. American Journal of
Physiology 266: Gastrointestinal and Liver Physiology 29, G140-G146.
[4]
Ch.
Kainz, H. Zeisler, P. Kohlberger, G. Gitsch, Harald Heinzl, G.
Breitenecker, A. Reinthaller (1994): Prognostic Value of Cytokeratins and
Carcinoembryonic Antigen Expression in Primary Surgically Treated Cervical
Cancer. Anticancer Research 14: 667-672.
[5]
A.
Gaiger, A. Neumeister, Harald Heinzl, I. Pabinger, S. Panzer (1994): HLA
class-I and -II antigens in chronic idiopathic autoimmune thrombocytopenia.
Annals of Hematology, Volume 68, Number 6, 299-302.
[6]
A.R.
Rosenkranz, E. Templ, O. Traindl, Harald Heinzl, G.J. Zlabinger (1994):
Reactive oxygen product formation by human neutrophils as an early marker for
biocompatibility of dialysis membranes. Clin. Exp. Immunol., 98: 300-305.
[7]
Julius
R. Lukas, Martin Aigner, Roland Blumer, Harald Heinzl, Robert Mayr (1994):
Number and Distribution of Neuromuscular Spindles in Human Extraocular Muscles.
Investigative Ophtalmology & Visual Science, Vol. 35, No. 13, 4317-4327.
[8]
Paul
Speiser, Jutta Stolzlechner, Karin Haider, Harald Heinzl, Raimund Jakesz,
Martin Pecherstorfer, Harald Rosen, Paul Sevelda, Robert Zeilliger (1994): pS2
Protein Status Fails to Be an Independent Prognostic Factor in an Average
Breast Cancer Population. Anticancer Research 14: 2125-2130.
[9]
Ch.
Kainz, G. Gitsch, C. Tempfer, Harald Heinzl, H. Koelbl, G. Breitecker, A.
Reinthaller (1994): Vascular Space Invasion and Inflammatory Stromal Reaction
as Prognostic Factors in Patients with Surgically Treated Cervical Cancer Stage
IB to IIB. Anticancer Research 14: 2245-2248.
[10]
G.
Gitsch, Ch. Kainz, A. Reinthaller, Harald Heinzl, G. Breitenecker (1995):
Inzidenz zervikaler intraepithelialer Neoplasien 1980-1989. Österreichische
Ärztezeitung 50/8, Seite 53-56.
[11]
Christian
Kainz, Gerald Gitsch, Harald Heinzl, Gerhard
Breitenecker (1995): Incidence of cervical smears indicating dysplasia among
Austrian women during the 1980s. British Journal of Obstetrics and Gynaecology,
Vol. 102, pp. 541-544.
[12]
C.
Kainz, C. Tempfer, G. Gitsch, Harald Heinzl, A.
Reinthaller, G. Breitenecker (1995): Influence of age and human
papillomavirus-infection on reliability of cervical cytopathology. Archives of
Gynecology and Obstetrics, 256, pp. 23-28.
[13]
Ch.
Kainz, P. Kohlberger, G. Sliutz, C. Tempfer, Harald Heinzl, A. Reinthaller, G.
Breitenecker, H. Koelbl (1995): Splice Variants of CD44 in Human Cervical
Cancer Stage IB to IIB. Gynecologic Oncology 57, 383-387.
[14]
Regine
Ahner, Christian Egarter, Herbert Kiss, Harald Heinzl, Robert Zeillinger,
Christian Schatten, Anke Dormeier, Peter Husslein (1995): Fetal fibronectin as
a selection criterion for induction of term labor. Am. J. Obstet. Gynecol.,
Volume 173, Number 5, 1513-1517. (My
first name has been misspelIed by the journal.)
[15]
R.
Windhager, K. Großschmidt, T. Tsuboyama, H. Siegl, Harald Heinzl, G. Seidl, H.
Plenk, Jr. (1996): Recorticalization after
Bifocal Internal Bone Transport in the Double-Plated Sheep Femur. Journal of
Orthopaedic Research, Vol. 14, No. 1, 94-101.
[16]
K.
Mayerhofer, J. Stolzlechner, S. Yildiz, K. Haider, Harald Heinzl, R. Jakesz, M.
Pecherstorfer, H. Rosen, P. Sevelda, R. Zeillinger, P. Speiser (1996):
Plasminogenaktivatorinhibitor 1 und Prognose beim Mammakarzinom. Geburtshilfe
und Frauenheilkunde, 56. Jahrgang, Heft 1, 23-27.
[17]
R.
Ladenstein, P.F. Ambros, Ch. Urban, I.M. Ambros, F.M. Fink, A. Zoubek, H.
Grienberger, K. Schmitt, R. Kerbl, E. Horcher, G. Amann, G. Höfler, Harald
Heinzl, H. Gadner, I. Mutz (1996): Wertigkeit prognostischer Faktoren in der
österreichischen A-NB87 Neuroblastom Studie. Klinische Pädiatrie, Zeitschrift
für Klinik und Praxis, Heft 4, Band 208, Seiten 210-220.
[18]
Petra
D. Kohlberger, Andreas Obermair, Gerhard Sliutz, Harald Heinzl, Heinz Koelbl,
Gerhard Breitenecker, Gerald Gitsch, Christian Kainz (1996): Quantitative Immunohistochemistry
of Factor VIII-Related Antigen in Breast Carcinoma. A Comparison of Computer-Assisted Image Analysis With Established Counting Methods. American Journal of
Clinical Pathology, Vol. 105, No. 6, pp. 705-710.
[19]
C.
Tempfer, A. Lösch, Harald Heinzl, G. Häusler, E. Hanzal, H. Kölbl, G.
Breitenecker, Ch. Kainz (1996):
Prognostic Value of Immunohistochemically Detected CD44 Isoforms CD44v5, CD44v6
and CD44v7-8 in Human Breast Cancer. European Journal of Cancer, Vol. 32A, No.
11, Pages 2023-2025.
[20]
G.
Haeusler, C. Tempfer, C. Kainz, Harald Heinzl(1996):
Menstrual phase and timing of breast cancer surgery: statistical aspects.
Letter to Editor, British Journal of Cancer 74, 1851-1852.
[21]
C.
Tempfer, G. Haeusler, Harald Heinzl, R. Kolb, E. Hanzal, Ch. Kainz (1996): Menstrual phase and breast cancer
surgery: influence on clinical outcome or pitfall of statistical analysis?
Cancer Letters 110, 145-148.
[22]
Harald
Heinzl, Alexandra Kaider, Gerhard Zlabinger (1996): Assessing Interactions of
Binary Time-Dependent Covariates with Time in Cox Proportional Hazards
Regression Models Using Cubic Spline Functions. Statistics in Medicine, Vol.
15, 2589-2601.
[23]
Harald
Heinzl (1996): A Note on Testing Areas Under the Curve when Using Destructive
Measurement Techniques. Journal of Pharmacokinetics and Biopharmaceutics
(renamed as Journal of Pharmacokinetics and Pharmacodynamics in 2001), Vol. 24,
No. 6, 651-655.
[24]
Harald
Heinzl, Alexandra Kaider (1997): Ein SAS-Macro zur Einbindung kubischer
Splinefunktionen ins proportionale Hazardsmodell von Cox. Konferenzbeiträge der
1. Konferenz der SAS-Benutzer in Forschung und Entwicklung (KSFE), Herausgeber:
Rechenzentrum der Humboldt-Universität zu Berlin, Seiten 208-227.
[25]
Harald
Heinzl, Alexandra Kaider (1997): Gaining more flexibility in Cox proportional
hazards regression models with cubic spline functions. Computer Methods and
Programs in Biomedicine 54, 201-208.
[26]
Harald
Heinzl (1997): Some further remarks on testing areas under the curve when using
destructive measurement techniques. American Statistical Association, 1997
Proceedings of the Biopharmaceutical Section, 129-131.
[27]
Jutta
Fischer-Colbrie, Armin Witt, Harald Heinzl, Paul Speiser, Klaus Czerwenka, Paul
Sevelda, Robert Zeillinger (1997): EGFR and Steroid Receptors in Ovarian Carcinoma:
Comparison with Prognostic Parameters and Outcome of Patients. Anticancer
Research 17, 613-620.
[28]
Sabine
Walser, Robert Hruby, Ernst Hesse, Harald Heinzl, Hermann Mascher (1997):
Preliminary Toxicokinetic Study with Different Crystal Forms of S (+)-Ibuprofen
(Dexibuprofen) and R,S-Ibuprofen in Rats.
Arzneimittel-Forschung/Drug Research 47 (I), 6, 750-754.
[29]
Nikolaus
Klupp, Daniele Risser, Harald Heinzl, Georg Bauer (1997): Forensic Autopsies
form 1984 to 1993 in Vienna, Austria. Journal of Forensic Sciences, Volume 42, Number 4, 675-677.
[30]
Petra
D. Kohlberger, Dirk G. Kieback, Dagmar Bancher, Elmar Stickeler, Harald Heinzl,
Gerald Gitsch, Gerhard Breitenecker, Christian Kainz (1997):
Immunohistochemical Detection of CD44 Splice Variant Expression in Premalignant
Lesions of the Cervix and Benign Cervical Epithelium. Gynecologic Oncology 66,
227-232.
[31]
H.
Kotzmann, C. Abela, J. Heindl, M. Clodi, M. Riedl, U. Barnas, Harald Heinzl, B.
Niederle, K. Geissler, W. Waldhäusl, A. Luger (1997): Effect of Successful
Parathyroidectomy on Hemotopoietic Progenitor Cells and Parameters of Red Blood
Cells in Patients with Primary Hyperparathyroidism. Horm. Metab. Res. 29,
387-392.
[32]
Regine
Ahner, Petra Kub-Csizi, Harald Heinzl, Diana Bikas, Michaela Rabl, Peter Wagenbichler, Peter Husslein (1997): The fast-reacting
fetal fibronectin test: A screening method for better prediction of the time of
delivery. Am. J. Obstet. Gynecol., Volume 177, Number 6, pp. 1478-1482.
[33]
Martin
Zehetmayer, Michael Georgopoulos, Irene Ruhswurm, Sabine Toma-Bständig, Klaus
Kitz, Adolf Ertl, Harald Heinzl (1998): Marginal Dose and Tumor Regression
after Stereotactic Irradiation for Uveal Melanoma. Kondziolka D. (ed.):
Radiosurgery 1997. Radiosurgery. Basel, Karger, vol. 2, pp. 114-120.
[34]
René
J. Wenzl, Harald Heinzl (1998): Localization of Matrix Metalloproteinase-2 in
Uterine Endometrium and Ectopic Implants. Gynecologic and Obstetric
Investigation 45: 253-257.
[35]
René
Wenzl, Rainer Lehner, Andrea Holzer, Ursula Windberger, Harald Heinzl, Udo M.
Losert (1998): Improved Laparoscopic Operating Techniques Using a Digital
Enhancement Video System. The Journal of the American Association of
Gynecologic Laparoscopists, Vol. 5, No. 2, 175-178.
[36]
C.
Tempfer, H. Zeisler, Harald Heinzl, L. Hefler, P. Husslein, Ch. Kainz (1998): Influence of Acupuncture on
Maternal Serum Levels of Interleukin-8, Prostaglandin F2alpha, and
Beta-Endorphin: A Matched Pair Study. Obstetrics & Gynecology, Vol. 92, No.
2, 245-248.
[37]
Julius-Robert
Lukas, Martin Aigner, Michaela Denk, Harald Heinzl, Martin Burian, Robert Mayr
(1998): Carbocyanine Postmortem Neuronal Tracing: Influence of Different
Parameters on Tracing Distance and Combination with Immunocytochemistry. The
Journal of Histochemistry & Cytochemistry, Volume 46(8): 901-910.
[38]
U.
Windberger, A. Bartholovitsch, G. Wollenek, Harald Heinzl, U. Losert (1998):
Comparison of erythrocyte aggregation and whole blood viscosity of the fetal
lamb (third quarter of gestation) and the adult sheep. Journal of Experimental
Animal Science, 39: 34-42.
[39]
Lukas
Hefler, Clemens Tempfer, Günther Häusler, Harald
Heinzl, Christian Kainz (1998): Zytokeratintumormarker beim Ovarialkarzinom:
Tissue Polypeptide Specific Antigen (TPS) und M3/M21. Wiener Klinische Wochenschrift, 110/18: 635-641.
[40]
C.
Tempfer, L. Hefler, Harald Heinzl, A. Loesch, G. Gitsch, H. Rumpold, C. Kainz
(1998): CYFRA 21-1 serum levels in women with adnexal masses and inflammatory
diseases. British Journal of Cancer, 78 (8):
1108-1112.
[41]
Lukas
Hefler, Clemens Tempfer, Harald Heinzl, Guenther Haeusler, Petra Steindl,
Christian Schneeberger, Gerald Gitsch, Christian Kainz
(1998): M3/M21 serum levels in women with adnexal masses and inflammatory
diseases. Int. J. Cancer (Pred. Oncol.), 79: 434-438.
[42]
R.
Lehner, R. Wenzl, Harald Heinzl, P. Husslein, P.
Sevelda (1998): Influence of Delayed Staging Laparotomy After Laparoscopic
Removal of Ovarian Masses Later Found Malignant. Obstetrics & Gynecology,
Vol. 92, No. 6, 967-971.
[43]
Guenther
Haeusler, Clemens Tempfer, Harald Heinzl, Christine Sam, Lukas Hefler, Engelbert Hanzal, Heinz Koelbl (1998): Value of urethral
pressure profilometry in the female incontinent patient: a prospective trial
with an 8-channel urethral catheter. Urology 52 (6): 1113-1117.
[44]
Martin
Zehetmayer, Irene Ruhswurm, Michael Georgopoulos, Sabine Toma-Bständig, Klaus
Kitz, Adolf Ertl, Karin Dieckmann, Günther Kren, Richard Pötter, Harald Heinzl
(1998): Stereotaktische Bestrahlung uvealer Melanome: Erste Wiener Ergebnisse.
Spektrum der Augenheilkunde 12/5: 171-174.
[45]
R.
Pirker, G. Pohl, T. Stranzl, R.W. Suchomel, Harald Heinzl, K.
Lechner, M. Filipits (1998): The Lung Resistance Protein (LRP) is an
independent prognostic factor in acute myeloid leukemia. Proceedings of the 17th
International Cancer Congress, Rio de Janeiro, Brazil, 24-28 August 1998, pp.
1337-1340.
[46]
Harald
Heinzl (1998): Flexible Beschreibung der Wechselwirkung zwischen einer binären
zeitabhängigen Kovariablen und der Zeit im Cox'schen Modell am Beispiel von
Transplantationsdaten. Berichte der ÖGKC, Jahrgang 21, Heft 1, 31-36.
[47]
M.
Schindl, K. Kerschan, A. Schindl, H. Schön, Harald
Heinzl, L. Schindl (1999): Induction of complete wound healing in recalcitrant
ulcers by low-intensity laser irradiation depends on ulcer cause and size.
Photodermatology, Photoimmunology & Photomedicine 15: 18-21.
[48]
M.
Sluga, R. Windhager, S. Lang, Harald Heinzl, S. Bielack, R. Kotz (1999): Local
and Systemic Control After Ablative and Limb Sparing Surgery in Patients With
Osteosarcoma. Clinical Orthopaedics and Related Research, Number 358, pp.
120-127.
[49]
C.
Peters-Engl, A. Obermair, Harald Heinzl, P. Buxbaum, P.
Sevelda, M. Medl (1999): CA 125 regression after two completed cycles of
chemotherapy: lack of prediction for long-term survival in patients with
advanced ovarian cancer. British Journal of Cancer 81(4), 662-666.
[50]
M.
Filipits, T. Stranzl, G. Pohl, Harald Heinzl, U. Jäger, K. Geissler, C.
Fonatsch, O.A. Haas, K. Lechner, R. Pirker (2000):
Drug resistance factors in acute myeloid leukemia: a comparative analysis.
Leukemia 14, 68-76.
[51]
Martin
Zehetmayer, Klaus Kitz, Rupert Menapace, Adolf Ertl, Harald Heinzl, Irene
Ruhswurm, Michael Georgopoulos, Karin Dieckmann, Richard Pötter (2000): Local
tumor control and morbidity after one to three fractions of stereotactic
external beam irradiation for uveal melanoma. Radiotherapy and Oncology 55,
135-144.
[52]
Peter
Birner, Harald Heinzl, Monika Schindl, Jiri Pumprla, Peter Schnider (2000):
Cardiac Autonomic Function in Patients Suffering from Primary Focal
Hyperhidrosis. European Neurology 44, 112-116.
[53]
Martin
Filipits, Ulrich Jaeger, Ingrid Simonitsch, Claudia Chizzali-Bonfadin, Harald
Heinzl, Robert Pirker (2000): Clinical Relevance of the Lung Resistance Protein
in Diffuse Large B-Cell Lymphomas. Clinical Cancer Research, Vol. 6, 3417-3423.
[54]
Janez
Stare, Harald Heinzl, Frank Harrell (2000): On the Use of Buckley and James
Least Squares Regression for Survival Data. New Approaches in Applied
Statistics, Anuška Ferligoj and Andrej Mrvar (Editors), Metodološki zvezki, 16,
Ljubljana: FDV, 125-134.
[55]
Harald
Heinzl (2000): Dangers of Using 'Optimal' Cutpoints in the Evaluation of
Cyclical Prognostic Factors. New Approaches in Applied Statistics, Anuška
Ferligoj and Andrej Mrvar (Editors), Metodološki zvezki, 16, Ljubljana: FDV,
135-143.
[56]
Harald
Heinzl (2000): Using SAS to calculate the Kent and O'Quigley measure of
dependence for Cox proportional hazards regression model. Computer Methods and
Programs in Biomedicine 63, 71-76.
[57]
Harald
Heinzl, Axel Muttray, Detlev Jung, Ameneh Hergert, Dirk-Matthias Rose, Johannes
Konietzko, Hans C. Hofmann, Christopher J. Portier, Lutz Edler (2000):
Exploring possible dose-response relationships between
2,3,7,8-tetrachlorodibenzo-p-dioxin concentration and heart rate variability in
humans. Organohalogen Compounds (ISBN 0-9703315-3-3), Vol. 48, 195-198.
[58]
Harald
Heinzl, Clemens Tempfer (2001): A cautionary note on segmenting a cyclical
covariate by minimum P-value search. Computational Statistics & Data
Analysis 35, 451-461.
[59]
Martina
Mittlböck, Harald Heinzl (2001): A note on R2 measures for Poisson and logistic
regression models when both models are applicable. Journal of Clinical
Epidemiology 54, 99-103.
[60]
Janez
Stare, Frank E. Harrell Jr, Harald Heinzl (2001): BJ: an S-Plus program to fit
linear regression models to censored data using the Buckley-James method.
Computer Methods and Programs in Biomedicine 64, 45-52.
[61]
Walter
Gall, Harald Heinzl, Peter Sachs (2001): Extracting a statistical data matrix
from electronic patient records. Computer Methods and Programs in Biomedicine
66, 153-166. Erratum in Computer Methods and Programs in Biomedicine 69 (2002),
257-259.
[62]
A.
Holzer, M. Greher, H. Hetz, H. Standhardt, A. Donner, Harald Heinzl, M. Zimpfer, U.M. Illievich (2001): Influence of aortic blood
flow velocity on changes of middle cerebral artery blood flow velocity during
isoflurane and sevoflurane anaesthesia. European Journal of Anaesthesiology 18,
238-244.
[63]
O.
Findl, W. Drexler, R. Menapace, Harald Heinzl, C.K.
Hitzenberger, A.F. Fercher (2001): Improved prediction of intraocular lens
power using partial coherence interferometry. Journal of Cataract and
Refractive Surgery 27(6), 861-867.
[64]
Florian
Mittermayer, Petra Krepler, Martin Dominkus, Eva Schwameis, Maria Sluga, Harald
Heinzl, Rainer Kotz (2001): Long-Term Followup of Uncemented Tumor
Endoprostheses for the Lower Extremity. Clinical Orthopaedics and Related
Research 388, 167-177.
[65]
F.
Eichler, O. Ipsiroglu, T. Arif, C. Popow, Harald Heinzl, M.
Urschitz, A. Pollak (2001): Position dependent changes of cerebral blood flow
velocities in premature infants. European Journal of Pediatrics 160(10),
633-639.
[66]
M.
Sluga, R. Windhager, S. Lang, Harald Heinzl, P. Krepler, F. Mittermayer, M.
Dominkus, A. Zoubek, R. Kotz (2001): The role of surgery and resection margins
in the treatment of Ewing’s sarcoma. Clinical Orthopaedics and Related Research
392, 394-399.
[67]
Lutz
Edler, Axel Muttray, Detlev Jung, Dirk-Matthias Rose, Johannes Konietzko,
Christopher J. Portier, Harald Heinzl (2001): Exploring possible dose-response
relationships between exposure to PCDDs/Fs and acquired dyschromatopsia in
humans. Organohalogen Compounds, Vol. 53, 309-312.
[68]
Lutz
Edler, Harald Heinzl (2001): Toxicokinetic modeling for environmental health
problems. International Conference on Statistical Challenges in Environmental
Health Problems, August 30 – September 1, 2001, Fukuoka, Japan. Extended
Abstracts, pp. 123-140.
[69]
Martina
Mittlböck, Harald Heinzl (2002): Measures of explained variation in gamma
regression models. Commun. Statist.-Simula., 31(1), 61-73.
[70]
Lutz
Edler, Harald Heinzl (2002): Exploring the relationships between exposure to
PCDDs/Fs and neurological health effects in humans. Organohalogen Compounds,
Vol. 57, 415-418.
[71]
Florian
Daxboeck, Karl Kircher, Robert Krause, Harald Heinzl, Christoph Wenisch, Gerold
Stanek (2002): Effect of Age on Antibody Titer to Mycoplasma pneumoniae. Scand.
J. Infect. Dis. 34: 577-579.
[72]
Petra
Kohlberger, Verena Muller-Klingspor, Harald Heinzl, Andreas Obermair, Gerhard
Breitenecker, Sepp Leodolter (2002): Prognostic Value of Laminin-5 in Serous
Adenocarcinomas of the Ovary. Anticancer Research 22: 3541-3544.
[73]
Lutz
Edler, Harald Heinzl, Detlev Jung, Axel Muttray
(2002): Neurological health effects related to exposure to dioxins and furans –
experiences from human studies in Germany. Proceedings of the Viet Nam – United
States Scientific Conference on Human Health and Environmental Effects of Agent
Orange/Dioxin. Part 2: Human Health Effects, pp. 704-725.
[74]
Harald
Heinzl, Janez Stare, Martina Mittlböck (2002): A Measure of Dependence for the Stratified
Cox Proportional Hazards Regression Model. Biometrical Journal, Volume 44,
Number 6, pp. 671-682.
[75]
Harald
Heinzl, Martina Mittlböck (2002): Adjusted R2 Measures for the Inverse Gaussian
Regression Model. Computational Statistics, Volume 17, Issue 4, pp. 525-544.
[76]
Harald
Heinzl, Lutz Edler (2002): Assessing uncertainty in a toxicokinetic model for
human lifetime exposure to TCDD. Organohalogen Compounds, Vol. 59, 355-358.
[77]
Harald
Heinzl, Lutz Edler (2003): Evaluating and assessing uncertainty of large-scaled
statistical analyses exemplified at the Boehringer TCDD cohort. Proceedings of
the Second workshop on Research Methodology (edited by: H.J. Adèr, G.J.
Mellenbergh), RM 2003, VU University, Amsterdam, pp. 87-94.
[78]
Harald
Heinzl, Martina Mittlböck (2003): Pseudo R-squared measures for Poisson
regression models with over- or underdispersion. Computational Statistics &
Data Analysis, 44:253-271.
[79]
Matthias
G. Wirtitsch, Oliver Findl, Barbara Kiss, Vanessa Petternel, Harald Heinzl,
Wolfgang Drexler (2003): Short-term effect of dorzolamide hydrochloride on
central corneal thickness in humans with cornea guttata. Arch Ophthalmol,
121(5):621-625.
[80]
Monika
Schindl, Sebastian F. Schoppmann, Thomas Ströbel, Harald Heinzl, Christina
Leisser, Reinhard Horvat, Peter Birner (2003): Level
of Id-1 protein expression correlates with poor differentiation, enhanced
malignant potential, and more aggressive clinical behavior of epithelial
ovarian tumors. Clinical Cancer Research, 9(2):779-785.
[81]
Karin
Dieckmann, Richard Pötter, Johannes Hofmann, Harald Heinzl, Wolfgang Wagner,
Günther Schellong; Pediatric Cooperative Hodgkin Disease Study Group of the
GPOH (2003): Does bulky disease at diagnosis influence outcome in childhood
Hodgkin's disease and require higher radiation doses? Results from the
German-Austrian Pediatric Multicenter Trial DAL-HD-90. Int J Radiation Oncology
Biol Phys, 56(3):644-652.
[82]
Martina
Mittlböck, Harald Heinzl (2003): Measures of explained variation for non-normal
outcomes. Proceedings of the Second workshop on Research Methodology (edited
by: H.J. Adèr, G.J. Mellenbergh), RM 2003, VU University, Amsterdam, pp. 47-50.
[83]
Lutz
Edler, Harald Heinzl (2003): Toxicokinetic modeling for environmetric health
problems. Environmetrics, 14/2:193-202.
[84]
C.
Buchta, M. Felfernig, P. Höcker, M. Macher, G.F. Körmöczi, P. Quehenberger, Harald Heinzl, P. Knöbl (2004): Stability of coagulation
factors in thawed, solvent/detergent-treated plasma during storage at 4 degrees
C for 6 days. Vox Sanguinis, 87(3):182-186.
[85]
Maneli
Mozaffarieh, Katharina Krepler, Harald Heinzl, Stefan
Sacu, Andreas Wedrich (2004): Visual function, quality of life and patient
satisfaction after ophthalmic surgery: a comparative study. Ophthalmologica,
218(1):26-30.
[86]
Erdem
Ergun, Harald Heinzl, Michael Stur (2004): Prognostic factors influencing
visual outcome of photodynamic therapy for subfoveal choroidal
neovascularization in pathologic myopia. Am J Ophthalmol, 138(3):434-438.
[87]
Lutz
Edler, Harald Heinzl, Martina Mittlböck (2004): Carrying-over Toxicokinetic
Model Uncertainty into Cancer Risk Estimates: The TCDD Example. Organohalogen
Compounds, Volume 66, pp. 3356-3362.
[88]
Harald
Heinzl, M. Mittlboeck (2004): Design Aspects of a Computer Simulation Study for
Assessing Uncertainty in Human Lifetime Toxicokinetic Models. COMPSTAT 2004,
Proceedings in Computational Statistics (Edited by J. Antoch), Physica-Verlag
Heidelberg (ISBN 3-7908-1554-3), pp. 199-211.
[89]
Harald
Heinzl, Thomas Waldhör, Martina Mittlböck (2005): Careful use of pseudo
R-squared measures in epidemiological studies. Statistics in Medicine,
24/18:2867-2872.
[90]
Harald
Heinzl, Martina Mittlboeck, Lutz Edler (2005): On the role of ex post
uncertainty assessment for risk management. International Journal of Risk
Assessment & Management, 5/2-4:206-215.
[91]
Martina
Mittlböck, Harald Heinzl (2005): Pseudo R-squared measures for generalized
linear models. Proceedings of 1st European Workshop on the
Assessment of Diagnostic Performance (Editors: E. Biganzoli, P. Boracchi, P.
Duca and E. Ifeachor), Milan, Italy, pp. 71-80 (ISBN 88-8399-084-6).
[92]
Maneli
Mozaffarieh, Harald Heinzl, Stefan Sacu, Andreas
Wedrich (2005): Clinical outcomes of phacoemulsification cataract surgery in
diabetes patients: visual function (VF-14), visual acuity and patient
satisfaction. Acta Ophthalmologica Scandinavica, 83:176-183.
[93]
Christoph
Buchta, Beatrice Hanslik-Schnabel, Roman Weigl, Jana List, Günther F. Körmöczi,
Maria Macher, Harald Heinzl, Paul Höcker, Axel Wanivenhaus, Martin Kurz (2005):
Quality of drainage blood: Survival of red cells after re-transfusion and
content of free hemoglobin and potassium. International Journal of Surgery,
3:250-253.
[94]
VPK
Nell, KP Machold, TA Stamm, G Eberl, H Heinzl, M Uffmann, JS Smolen, G Steiner
(2005): Autoantibody profiling as early diagnostic and prognostic tool for
rheumatoid arthritis. Annals of the Rheumatic Diseases, 64:1731-1736.
[95]
F.
Daxboeck, S. Mustafa, O. Assadian, Harald Heinzl, M. Stadler, A.M. Hirschl, W. Koller (2005): Accuracy of antibiotyping
using standard antibiograms compared with 16S-23S ribosomal spacer PCR for
diagnosis of MRSA. European Journal of Clinical Microbiology & Infectious
Diseases, 24:640-642.
[96]
Hannes
Rieger, Stefan Kuhle, Osman S. Ipsiroglu, Harald
Heinzl, Christian N. Popow (2005): Effects of open vs. closed system
endotracheal suctioning on cerebral blood flow velocities in mechanically
ventilated extremely low birth weight infants. Journal of Perinatal Medicine,
33:435-441.
[97]
Rodrig
Marculescu, Gottfried Sodeck, Hans Domanovits, Gerhard Hobusch, Markus Exner,
Harald Heinzl, Kurt Huber, Christine Mannhalter, Erich Minar, Oswald Wagner,
Martin Schillinger (2005): Interleukin-1 gene cluster variants and abdominal
aortic aneurysms. Thrombosis and Haemostasis, 94/3:646-650.
[98]
Christoph
Buchta, Claudia Bittner, Harald Heinzl, Paul Höcker, Maria Macher, Matthias
Mayerhofer, Rainer Schmid, Christoph Seger, Markus Dettke (2005):
Transfusion-related exposure to the plasticizer di(2-ethylhexyl)phthalate
in patients receiving plateletpheresis concentrates. Transfusion, 45:798-802.
[99]
KA
Borchhardt, H Heinzl, A Gessl, WH Hörl, K Kaserer, G Sunder-Plassmann (2006):
Calcitonin concentrations in patients with chronic kidney disease and medullary
thyroid carcinoma or c-cell hyperplasia. Kidney International, 70:2014-2020.
[100] Maneli Mozaffarieh, Harald Heinzl, Stefan Sacu,
Andreas Wedrich (2006): In-patient management and treatment satisfaction after
intravitreous plasminogen activator injection. Graefe’s Archive for Clinical
and Experimental Ophthalmology, 244:1421-1428.
[101] C. Haberler, I. Slavc, T. Czech, E. Gelpi, Harald
Heinzl, H. Budka, C. Urban, M. Scarpatetti, G. Ebetsberger-Dachs, C. Schindler,
N. Jones, A. Klein-Franke, H. Maier, B. Jauk, A.
Kiefer, J.A. Hainfellner (2006): Histopathological prognostic factors in
medulloblastoma: High expression of survivin is related to unfavourable
outcome. European Journal of Cancer, 42:2996-3003.
[102] M Preusser, U Laggner, C Haberler, H Heinzl, H Budka, JA Hainfellner (2006): Comparative analysis of NeuN
immunoreactivity in primary brain tumours: conclusions for rational use in
diagnostic histopathology. Histopathology, 48:438-444.
[103] Matthias Preusser, Harald Heinzl, Ellen Gelpi,
Katharina Schonegger, Christine Haberler, Peter Birner, Christine Marosi,
Monika Hegi, Thierry Gorlia, Johannes A. Hainfellner (2006): Histopathologic
Assessment of Hot-Spot Microvessel Density and Vascular Patterns in
Glioblastoma: Poor Observer Agreement Limits Clinical Utility as Prognostic
Factors. Cancer, 107:162-170.
[104] Christoph Buchta, Alexander Blacky, Gerda C.
Leitner, Harald Heinzl, Günther F. Körmöczi, Maria Macher, Paul Höcker (2006):
Surface disinfection of packed red blood cells with 70% ethanol. International
Journal of Surgery, 4:118-121.
[105] Thomas Waldhoer, Gerald Haidinger, Martin Wald,
Harald Heinzl (2006): Non-random geographical distribution of infant mortality
in Austria 1984-2002. Wiener Klinische Wochenschrift, 118/11-12:341-347.
[106] Waldhoer T., Heinzl H. (2006): Spatial
distribution of infant mortality based on district and community level in
Austria. Conference Proceedings, Spatial Epidemiology Conference, 23-25 May
2006, London, UK, pp. 119-123.
[107] M. Mittlböck, Harald Heinzl(2006):
A simulation study comparing properties of heterogeneity measures in
meta-analyses. Statistics in Medicine, 25/24:4321-4333.
[108] Harald Heinzl, Martina Mittlböck, Lutz Edler
(2007): On the translation of uncertainty from toxicokinetic to toxicodynamic
models – The TCDD example. Chemosphere, 67/9:S365-S374.
[109] Harald Heinzl, Martina Mittlböck (2007): Eine
Einführung zu chirurgischen Lernkurvenstudien aus Sicht der medizinischen
Statistik und Dokumentation. Forum der Medizin_Dokumentation und
Medizin_Informatik, 9/1:30-33.
[110] Harald Heinzl, Axel Benner, Carina Ittrich,
Martina Mittlböck (2007): Proposals for Sample Size Calculation Programs.
Methods of Information in Medicine, Vol. 46, Issue 6, pp. 655-661.
[111] Andrea Michalek-Sauberer, Harald Heinzl, Sabine M. Sator-Katzenschlager, Gabriel Monov, Erich Knolle,
Hans Georg Kress (2007): Perioperative Auricular Electroacupuncture Has no
Effect on Pain and Analgesic Consumption After Third Molar Tooth Extraction.
Anesthesia & Analgesia, 104/3:542-547.
[112] Georg Rainer, Katharina Emanuela Schmid, Oliver
Findl, Stefan Sacu, Barbara Kiss, Harald Heinzl, Rupert Menapace (2007):
Natural Course of Intraocular Pressure after Cataract Surgery with Sodium
Hyaluronate 1% versus Hydroxypropylmethylcellulose 2%. Ophthalmology,
114:1089-1093.
[113] D. Doberer, M. Gschwandtner, W. Mosgoeller, C.
Bieglmayer, Harald Heinzl, V. Petkov (2007): Pulmonary and systemic effects of
inhaled PACAP38 in healthy male subjects. European Journal of Clinical
Investigation, 37/8:665-672.
[114] Matthias G. Wirtitsch, Oliver Findl, Harald
Heinzl, Wolfgang Drexler (2007): Effect of Dorzolamide Hydrochloride on Central
Corneal Thickness in Humans With Cornea Guttata.
Archives of Ophthalmology, Vol. 125, No. 10, pp. 1345-1350.
[115] Matthias G. Wirtitsch, Rupert Menapace, Michael
Georgopoulos, Georg Rainer, Wolf Buehl, Harald Heinzl
(2007): Intraocular pressure rise after primary posterior continuous
curvilinear capsulorhexis with a fixed dorzolamide-timolol combination:
Randomized safety study with intraindividual comparison using an angulated and
a nonangulated intraocular lens. Journal of Cataract & Refractive Surgery,
Vol. 33, Issue 10, pp. 1754-1759.
[116] Andrea Michalek-Sauberer, Sibylle A.
Kozek-Langenecker, Harald Heinzl, Engelbert Deusch,
Astrid Chiari (2008): Median Effective Local Anesthetic Doses of Plain
Bupivacaine and Ropivacaine for Spinal Anesthesia Administered Via a Spinal
Catheter for Brachytherapy of the Lower Abdomen. Regional Anesthesia and Pain
Medicine, Vol. 33, No. 1, pp. 4-9.
[117] Wolf Buehl, Harald Heinzl, Martina Mittlboeck,
Oliver Findl (2008): Statistical problems caused by missing data resulting from
neodymium:YAG laser capsulotomies in long-term
posterior capsule opacification studies: Problem identification and possible
solutions. Journal of Cataract & Refractive Surgery, Vol. 34, Issue 2, pp.
268-273.
[118] Thomas Waldhoer, Martin Wald, Harald Heinzl
(2008): Analysis of the spatial distribution of infant mortality by cause of
death in Austria in 1984 to 2006. International Journal of Health Geographics,
7:21 (9 pages).
[119] Ellen Gelpi, Harald Heinzl, Romana Höftberger,
Ursula Unterberger, Thomas Ströbel, Till Voigtländer, Edita Drobner, Christa
Jarius, Susanna Lang, Thomas Waldhör, Hanno Bernheimer, Herbert Budka (2008):
Creutzfeldt-Jakob Disease in Austria: An Autopsy-Controlled Study.
Neuroepidemiology, Vol. 30, No. 4, pp. 215-221.
[120] M Preusser, H Heinzl, E Gelpi, R Höftberger, I
Fischer, I Pipp, I Milenkovic, A Wöhrer, F Popovici, S Wolfsberger, J A Hainfellner (2008): Ki67 index in intracranial ependymoma:
a promising histopathological candidate biomarker. Histopathology, Vol. 53,
Issue 1, pp. 39-47.
[121] Matthias Preusser, Robert Charles Janzer, Jörg
Felsenberg, Guido Reifenberger, Marie-France Hamou, Annie-Claire Diserens,
Roger Stupp, Thierry Gorlia, Christine Marosi, Harald Heinzl, Johannes A Hainfellner, Monika Hegi (2008):
Anti-O6-Methylguanine-Methyltransferase (MGMT) Immunohistochemistry in
Glioblastoma Multiforme: Observer Variability and Lack of Association with
Patient Survival Impede Its Use as Clinical Biomarker. Brain Pathology, Vol.
18, Issue 4, pp. 520-532.
[122] Kyra A. Borchhardt, Harald Heinzl, Elisabeth
Mayerwöger, Walter H. Hörl, Martin Haas, Gere Sunder-Plassmann (2008):
Cinacalcet Increases Calcium Excretion in Hypercalcemic Hyperparathyroidism
After Kidney Transplantation. Transplantation, Vol. 86, Number 7, pp. 919-924.
[123] Harald Heinzl, Martina Mittlböck, Lutz Edler
(2008): Technical uncertainty in the back-calculation of occupational exposure
to dioxins. Statistics in Medicine, Vol. 27, Issue 12, pp. 2214-2233.
[124] Harald Heinzl (2009): Kaplan-Meier-Kurven und die
Hazard Ratio. krebs:hilfe!, Heft 2, Seiten X-XI.
[125] Maneli Mozaffarieh, Harald Heinzl, Stefan Sacu,
Andreas Wedrich (2009): Second Eye Cataract Surgery in the Diabetes Patient?
Quality of Life Gains and Speed of Visual and Functional Rehabilitation.
Ophthalmic Research, Vol. 41, pp. 2-8.
[126] K. Schoenegger, S. Oberndorfer, B. Wuschitz, W.
Struhal, J. Hainfellner, D. Prayer, Harald Heinzl, H. Lahrmann, C. Marosi and
W. Grisold (2009): Peritumoral edema on MRI at initial diagnosis: an
independent prognostic factor for glioblastoma? European Journal of Neurology,
Vol. 16, pp. 874-878.
[127] P. Wexberg, W. Sperker, N.G. Morgenthaler, Harald
Heinzl, C. Adlbrecht, C. Plass, H.D. Glogar, I.M.
Lang, T. Neunteufl (2009): Inhomogeneous vasomotor effects of moderate
selective and non-selective endothelin-receptor blockade in stable coronary
artery disease. Heart, Vol. 95, pp. 1258-1264.
[128] Martin Filipits, Margaretha Rudas, Harald Heinzl,
Raimund Jakesz, Ernst Kubista, Sigurd Lax, Walter Schippinger, Otto Dietze,
Richard Greil, Wolfgang Stiglbauer, Werner Kwasny, Alexander Nader, Michael
Stierer, and Michael F.X. Gnant for the Austrian Breast and Colorectal Cancer
Study Group (2009): Low p27 Expression Predicts Early Relapse and Death in
Postmenopausal Hormone Receptor-Positive Breast Cancer Patients Receiving
Adjuvant Tamoxifen Therapy. Clinical Cancer Research, Vol. 15, Number 18, pp.
5888-5894.
[129] Adelheid Wöhrer, Thomas Waldhör, Harald Heinzl,
Monika Hackl, Johann Feichtinger, Ulrike Gruber-Mösenbacher, Andreas Kiefer,
Hans Maier, Reinhard Motz, Angelika Reiner-Concin, Bernd Richling, Carmen
Idriceanu, Michael Scarpatetti, Roland Sedivy, Hans-Christian Bankl, Wolfgang
Stiglbauer, Matthias Preusser, Karl Rössler, Johannes Andreas Hainfellner
(2009): The Austrian Brain Tumour Registry: a cooperative way to establish a
population-based brain tumour registry. Journal of Neuro-Oncology, Vol. 95,
Number 3, pp. 401-411.
[130] V. Nell-Duxneuner, K. Machold, T. Stamm, G.
Eberl, Harald Heinzl, E. Hoefler, J.S. Smolen, G.
Steiner (2010): Autoantibody profiling in patients with very early rheumatoid
arthritis: a follow-up study. Annals of the Rheumatic Diseases, Vol. 69, Issue
1, pp. 169-174.
[131] Wolfgang Gartner, Aysegül Ilhan, Dashurie Neziri,
Wolfgang Base, Michael Weissel, Adelheid Wöhrer, Harald Heinzl, Thomas Waldhör,
Ludwig Wagner, and Matthias Preusser (2010): Elevated blood markers 1 year
before manifestation of malignant glioma. Neuro-Oncology 12(9):1004-1008.
[132] Adelheid Woehrer, Irene Slavc, Thomas Waldhoer,
Harald Heinzl, Nadine Zielonke, Thomas Czech, Martin Benesch, Johannes A.
Hainfellner, and Christina Haberler on behalf of the Austrian Brain Tumor
Registry (2010): Incidence of Atypical Teratoid/Rhabdoid Tumors in Children. A
Population-Based Study by the Austrian Brain Tumor Registry, 1996–2006. Cancer
116(24):5725-5732.
[133] D Doberer, A Haschemi, M Andreas, T-C Zapf, B
Clive, M Jeitler, H Heinzl, O Wagner, M Wolzt and M Bilban (2010): Haem
arginate infusion stimulates haem oxygenase-1 expression in healthy subjects.
British Journal of Pharmacology 161(8):1751-1762.
[134] J.A. Hainfellner and Harald Heinzl (2010):
Neuropathological biomarker candidates in brain tumors: key issues for
translational efficiency. Clinical Neuropathology, Vol. 29, No. 1, pp. 41-54.
[135] Thomas Waldhoer and Harald Heinzl (2011): Combining
difference and equivalence test results in spatial maps. International Journal
of Health Geographics, 10:3 (10 pages).
[136] Harald Heinzl and Thomas Waldhoer (2011):
Difference and equivalence tests in spatial maps. Proceedings of the 4th
International Conference on Risk Analysis-ICRA 4, edited by Alex Karagrigoriou,
University of Cyprus, Nicosia, pp. 151-156 (ISBN: 978-9963-9965-0-6).
[137] Manuela Schmidinger, Ursula M. Vogl, Marija
Bojic, Wolfgang Lamm, Harald Heinzl, Andrea Haitel, Martin Clodi, Gero Kramer,
and Christoph C. Zielinski (2011): Hypothyroidism in Patients With Renal Cell
Carcinoma. Blessing or Curse? Cancer, Vol. 117, Issue 3, pp. 534-544.
[138] Johannes J. Kovarik, Wolfgang Tillinger, Johannes
Hofer, Markus A. Hölzl, Harald Heinzl, Marcus D. Saemann and Gerhard J.
Zlabinger (2011): Impaired anti-inflammatory efficacy of n-butyrate in patients with IBD. European Journal of Clinical
Investigation, Vol. 41, Issue 3, pp. 291-298.
[139] Matthias Preusser, Katarzyna Elandt, Ilse
Schwarzinger, Christine Marosi, Harald Heinzl (2011): Immature and absolute
platelet count changes and thrombocytopenia in malignant glioma. European
Journal of Clinical Investigation, Vol. 41, Issue 5, pp. 539-545.
[140] D. Bonderman, P. Wexberg, A.M. Martischnig, H. Heinzl,
M-B. Lang, R. Sadushi, N. Skoro-Sajer, I.M. Lang (2011): A non-invasive
algorithm to exclude precapillary pulmonary hypertension. European Respiratory
Journal, Vol. 37, Issue 5, pp. 1096-1103.
[141] Thomas Waldhoer and Harald Heinzl (2011): Choosing the
wrong alternative hypothesis in spatial maps. Proceedings of the 4th
International Conference on Risk Analysis-ICRA 4, edited by Alex Karagrigoriou,
University of Cyprus, Nicosia, pp. 319-321 (ISBN: 978-9963-9965-0-6).
[142] Thomas Waldhoer and Harald Heinzl (2011): Accepting
the Wrong Alternative Hypothesis in Spatial Maps. Numerical Analysis and
Applied Mathematics ICNAAM 2011, AIP Conference Proceedings 1389, pp. 430-432
(ISBN: 978-0-7354-0956-9).
[143] Anna Sophie Berghoff, Harald Stefanits, Harald Heinzl
and Matthias Preusser (2012): Clinical Neuropathology Practice News 4-2012:
levels of evidence for brain tumor biomarkers. Clinical Neuropathology,
31(4):206-209.
[144] Matthias Preusser, Romana Hoeftberger, Adelheid
Woehrer, Ellen Gelpi, Mathilde Kouwenhoven, Johan M Kros, Marc Sanson, Ahmed
Idbaih, Alba A Brandes, Harald Heinzl, Thierry Gorlia,
Johannes A Hainfellner, Martin van den Bent (2012): Prognostic value of Ki67
index in anaplastic oligodendroglial tumours – a translational study of the
European Organization for Research and Treatment of Cancer Brain Tumor Group.
Histopathology 60(6):885–894.
[145] Sebastian F. Schoppmann, Anna Berghoff, Carina Dinhof,
Raimund Jakesz, Michael Gnant, Peter Dubsky, Bettina Jesch, Harald
Heinzl, Peter Birner (2012): Podoplanin-expressing cancer-associated
fibroblasts are associated with poor prognosis in invasive breast cancer.
Breast Cancer Research and Treatment 134(1):237–244.
[146] Elisabeth Puchhammer-Stöckl, Stephan W. Aberle, Harald
Heinzl (2012): Association of age and gender with alphaherpesvirus infections
of the central nervous system in the immunocompetent host. Journal of Clinical
Virology 53(4):356-359.
[147] Matthias Preusser, Gerhard Fülöp, Anna Sophie
Berghoff, Harald Heinzl, Guenther G. Steger, Richard Greil, Christoph C.
Zielinski, Rupert Bartsch (2012): Influence of the American ODAC Statement upon
Austrian Prescription Practice of Bevacizumab in Metastatic Breast Cancer. The
Oncologist 17(7):e13-e17.
[148] Anna Probst, Susanne Humpeler, Harald Heinzl, Gerhard
Blasche, Cem Ekmekcioglu (2012): Short-term effect of macronutrient composition
and glycemic index of a yoghurt breakfast on satiety and mood in healthy young
men. Forschende Komplementärmedizin 19(5):247-251.
[149] Diana Bonderman, Paul Wexberg, Harald Heinzl, Irene M.
Lang (2012): Non-invasive algorithms for the diagnosis of pulmonary
hypertension. Thrombosis and Haemostasis 108(6):1037-1041.
[150] Harald Heinzl, Philipp Bloching (2012): Quantitative
assessment of scientific quality. Numerical Analysis and Applied Mathematics
ICNAAM 2012, AIP Conference Proceedings 1479, pp. 424-426 (ISBN:
978-0-7354-1091-6).
[151] Harald Heinzl, Thomas Waldhoer (2012): Relevance of
the type III error in epidemiological maps. International Journal of Health
Geographics, 11:34.
[152] Philipp A. Bloching, Harald Heinzl (2013): Assessing
the scientific relevance of a single publication over time. South African
Journal of Science 109(9/10):93-94.
[153] Aysegul Ilhan-Mutlu, Ludwig Wagner, Georg Widhalm,
Adelheid Wöhrer, Sophie Bartsch, Thomas Czech, Harald Heinzl, Fritz Leutmezer,
Daniela Prayer, Christine Marosi, Wolfgang Base, Matthias Preusser (2013):
Exploratory investigation of eight circulating plasma markers in brain tumor
patients. Neurosurgical Review 36(1):45-55; discussion 55-56.
[154] Wolfgang Sieghart, Florian Hucke, Matthias Pinter, Ivo
Graziadei, Wolfgang Vogel, Christian Müller, Harald Heinzl, Michael Trauner,
Markus Peck-Radosavljevic (2013): The ART of decision making: retreatment with
transarterial chemoembolization in patients with hepatocellular carcinoma.
Hepatology 57(6):2261-2273.
[155] Gabor G. Kovacs, Ivan Milenkovic, Adelheid Wöhrer,
Romana Höftberger, Ellen Gelpi, Christine Haberler, Selma Hönigschnabl,
Angelika Reiner-Concin, Harald Heinzl, Susanne Jungwirth, Wolfgang Krampla, Peter Fischer, Herbert Budka (2013): Non-Alzheimer neurodegenerative
pathologies and their combinations are more frequent than commonly believed in
the elderly brain: a community-based autopsy series. Acta Neuropathologica
126(3):365-384.
[156] Anna S. Berghoff, Harald Stefanits, Adelheid Woehrer,
Harald Heinzl, Matthias Preusser, Johannes A.
Hainfellner (2013): Clinical Neuropathology Practice Guide 3-2013: levels of
evidence and clinical utility of prognostic and predictive candidate brain
tumor biomarkers. Clinical Neuropathology 32(3):148-158.
[157] Florian Hucke, Wolfgang Sieghart, Matthias Pinter, Ivo
Graziadei, Wolfgang Vogel, Christian Müller, Harald Heinzl, Fredrik Waneck, Michael Trauner, Markus Peck-Radosavljevic (2014): The
ART-strategy: Sequential assessment of the ART score predicts outcome of
patients with hepatocellular carcinoma re-treated with TACE. Journal of
Hepatology 60(1):118-126.
[158] J Gerry Coghlan, Christopher P Denton, Ekkehard
Grünig, Diana Bonderman, Oliver Distler, Dinesh Khanna, Ulf Müller-Ladner, Janet
E Pope, Madelon C Vonk, Martin Doelberg, Harbajan Chadha-Boreham, Harald
Heinzl, Daniel M Rosenberg, Vallerie V McLaughlin, James R Seibold; on behalf
of the DETECT study group (2014): Evidence-based detection of pulmonary
arterial hypertension in systemic sclerosis: the DETECT study. Annals of the
Rheumatic Diseases 73(7):1340-1349.
[159] A. S. Berghoff, A. Ilhan-Mutlu, A. Wöhrer, M. Hackl,
G. Widhalm, J. A. Hainfellner, K. Dieckmann, T. Melchardt, B. Dome, Harald
Heinzl, P. Birner, M. Preusser (2014): Prognostic significance of Ki67
proliferation index, HIF1 alpha index and microvascular density in patients
with non-small cell lung cancer brain metastases. Strahlentherapie und
Onkologie 190(7):676-685.
[160] F. Hucke, M. Pinter, I. Graziadei, S. Bota, W. Vogel, C.
Müller, Harald Heinzl, F. Waneck, M. Trauner, M. Peck-Radosavljevic, W.
Sieghart (2014): How to STATE suitability and START transarterial
chemoembolization in patients with intermediate stage hepatocellular carcinoma.
Journal of Hepatology 61(6):1287-1296.
[161] M. Bienkowski, A. S. Berghoff, C. Marosi, A. Wöhrer,
Harald Heinzl, J. A. Hainfellner, M. Preusser (2015):
Clinical Neuropathology practice guide 5-2015: MGMT methylation pyrosequencing
in glioblastoma: unresolved issues and open questions. Clinical Neuropathology
34(5):250-257.
[162] A. Araki, M. Chocholous, J. Gojo, C. Dorfer, T. Czech,
Harald Heinzl, K. Dieckmann, I. M. Ambros, P. F. Ambros, I. Slavc, C. Haberler
(2016): Chromosome 1q gain and tenascin-C expression are candidate markers to
define different risk groups in pediatric posterior fossa ependymoma. Acta
Neuropathologica Communications 4(1):88 (10 pages).
[163] A. S. Berghoff, E. Fuchs, G. Ricken, B. Mlecnik, G.
Bindea, T. Spanberger, M. Hackl, G. Widhalm, K. Dieckmann, D. Prayer, A.
Bilocq, Harald Heinzl, C. Zielinski, R. Bartsch, P. Birner, J.
Galon, M. Preusser (2016): Density of tumor-infiltrating lymphocytes correlates
with extent of brain edema and overall survival time in patients with brain
metastases. Oncoimmunology 5(1):e1057388 (8 pages).
[164] Harald Heinzl, M. Mittlboeck (2017): Assessing a
hypothesis test for the difference between two quantiles from independent
populations. Communications in Statistics: Simulation and Computation
46(5):3540-3552.
[165] Thomas Waldhoer, Harald Heinzl (2017): Exploring the
possible relationship between ambient heat and sudden infant death with data
from Vienna, Austria. PLoS ONE 12(9): e0184312.
[166] Ulrike Pötschger, Harald Heinzl, Maria Grazia
Valsecchi and Martina Mittlböck (2018): Assessing the effect of a partly
unobserved, exogenous, binary time-dependent covariate on survival
probabilities using generalised pseudo-values. BMC Medical Research Methodology
18:14 (11 pages).
[167] Harald Heinzl, Martina Mittlboeck (2018): Visualizing
the quantile survival time difference curve. Journal of Evaluation in Clinical
Practice 24(4):708-712.
[168]
Harald Heinzl, Martina Mittlboeck (2018): Contribution
to the discussion of “When should meta-analysis avoid making hidden normality
assumptions?” Biometrical Journal 60(6):1085-1086.
[169] Georg Duftschmid, Christoph Rinner, Simone Katja Sauter, Gottfried Endel, Peter Klimek, Christoph Mitsch, Harald Heinzl (2019): Patient-Sharing Relations in the Treatment of Diabetes and Their Implications for Health Information Exchange: Claims-Based Analysis. JMIR Medical Informatics 7(2):e12172.
[170]
Hans-Peter Hutter, Thomas Waldhoer, Katja Müller, Monika Hackl, Lisbeth Weitensfelder, Harald Heinzl (2019): Cancer incidence in an Austrian alpine valley 1983–2012. Wiener klinische Wochenschrift (https://doi.org/10.1007/s00508-019-1476-7).
Book Chapters:
[bc1] T. Kapitany, Harald Heinzl, G. Sonneck (1995):
Effekte gezielter und ungezielter Medienaktionen auf die Inanspruchnahme des
Kriseninterventionszentrums. In: Krisenintervention und Suizidverhütung. Ein
Leitfaden für den Umgang mit Menschen in Krisen. Herausgegeben von G. Sonneck.
Mit einem Geleitwort von E. Ringel †. Facultas Universitätsverlag: Wien, 3. verbesserte und erweiterte
Auflage, Seiten 242-244.
[bc2] Lutz Edler, Annette Kopp-Schneider, Harald Heinzl
(2005): Dose-Response Modeling. Chapter
13 in: Recent Advances in Quantitative Methods in Cancer and Human Health Risk
Assessment. Edited by Lutz Edler and Christos P. Kitsos. John Wiley & Sons:
Chichester, pp. 211-237.
Book Reviews:
[br1] Harald Heinzl (2001): Book review
of “Analysis of multivariate survival data” by Philip Hougaard, 2000.
Zentralblatt MATH, Zbl 0962.62096.
[br2] Harald Heinzl (2009): Book review
of “The statistical analysis of recurrent events” by Richard J. Cook and Jerald
F. Lawless, 2007. Zentralblatt MATH, Zbl 1159.62061.
[br3]
Harald Heinzl (2010): Book review of “Survival
analysis for epidemiologic and medical research. A practical guide” by Steve
Selvin, 2008. Zentralblatt MATH, Zbl 1182.62208.
[br4]
Harald Heinzl (2013): Book review of “Principles of
Uncertainty” by Joseph B. Kadane, 2011. Biometrical Journal 55(4):640-641.
[br5]
Harald Heinzl (2014): Book review of “Bayesian
adaptive methods for clinical trials” by Scott M. Berry, Bradley P. Carlin, J.
Jack Lee, and Peter Müller, 2011. Zentralblatt MATH, Zbl 1306.62005.